Modified C-3 betulinic acid derivatives as HIV maturation inhibitors
Compounds having drug and bio-affecting properties, their pharmaceutical compositions and methods of use are set forth. In particular, modified C-3 betulinic acid and other structurally related natural products derivatives that possess unique antiviral activity are provided as HIV maturation inhibitors. These compounds are useful for the treatment of HIV and AIDS.
Bristol-Myers Squibb Company
A A C A
A61P A61P C07J A61P
inventional inventional inventional inventional
Jie Sing-Yuen Alicia Ny Zheng Nicholas A. Jacob
Chen Sit Regueiro-Ren Sin Liu Meanwell Swidorski